Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07856706
PHASE1
A Single Ascending Dose, and Food Effect Study of ABBV-7828 in Healthy Adults
Sponsor: AbbVie
View on ClinicalTrials.gov
Summary
This study is to evaluate safety, tolerability, pharmacokinetics and effect of food on ABBV-7828 compared to placebo in healthy adult participants.
Official title: A Phase 1, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-7828, and to Evaluate the Effect of Food on ABBV-7828 Pharmacokinetics in Healthy Adult Subjects
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-09-21
Completion Date
2027-05
Last Updated
2026-10-05
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
ABBV-7828
Oral administration
DRUG
Placebo for ABBV-7828
Oral administration
Locations (1)
Acpru /Id# 283545
Grayslake, Illinois, United States